Executive Lead for Collections Services and Science and Industry Museum Director Sally MacDonald reflects on how our value of being open for all is reflected in our approach to collecting and curation.
Embedding sustainability in the Science Museum Group’s working practices is not just a priority for the museums and sites, but for the exhibition touring programme too. Here, Emily Cronin, Partnerships Manager (Cultural & Commercial Partnerships) explains more.
How do you know which vaccine research to back when a pandemic starts? Roger Highfield, Science Director, talks to Kate Bingham, former chair of the UK Government’s Vaccine Taskforce.
Roger Highfield, Science Director, talks to the scientist behind the world’s first COVID-19 vaccine that requires only a single dose.
For the first time, scientists can see a pandemic evolve in real time at the genetic level, revealing ‘variants of concern’ while guarding for large-scale genetic changes in COVID-19 that might occur by a process called recombination.
In the latest blog in our Open for All series, we look at the role disability has played in advancing scientific techniques.
In the first of the Science Museum Group’s global Climate Talks series, Climate Change: Why Should We Care? – broadcaster and mathematician Dr Hannah Fry was joined by the legendary conservationist Dr Jane Goodall, Kenyan climate activist Wanjũhĩ Njoroge, climate advocate Kira Peter-Hansen MEP and scientist Dr Tamsin Edwards to explore how climate change will impact the future of our planet and why we need to act now to deal with the challenges posed by it.
Mutant versions of the SARS-CoV-2 virus have set off alarms worldwide. Science Director Roger Highfield talks to one of the laboratories racing to find out what these variants mean for COVID-19 transmissibility and virulence, along with the development of drugs and vaccines.
Sir Ian Blatchford reflects on the achievements of former Science Museum Director Dame Margaret Weston, who sadly died in January 2021.
Details of the Oxford COVID-19 vaccine are published today, showing encouraging efficacy and some puzzling features. Science Director, Roger Highfield, talks to the trial’s Chief Investigator about the vaccine, trial regulation and a surprising bonus result.